THERAPEUTICSMD INC (TXMD) Stock Balance Sheet
NASDAQ:TXMD - Nasdaq - US88338N2062 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.75M | 5.06M | 4.33M | 38.10M | 64.90M | |||
| Receivables | 3.00M | 3.56M | 3.09M | N/A | 36.18M | |||
| Inventories | N/A | N/A | N/A | N/A | 7.62M | |||
| Other Current Assets | 3.77M | 3.64M | 4.38M | 17.30M | 54.50M | |||
| Total Current Assets | 12.51M | 12.26M | 11.80M | 55.40M | 119.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.95M | 6.10M | 6.87M | 7.70M | 9.10M | |||
| Intangibles | 4.14M | 4.32M | 6.10M | 6.90M | 7.10M | |||
| Other Non-Current Assets | 211.00K | 130.00K | 58.00K | 300.00K | 33.80M | |||
| Total Non-Current Assets | 25.72M | 26.56M | 31.51M | 35.10M | 50.00M | |||
| TOTAL ASSETS | 38.24M | 38.82M | 43.31M | 90.50M | 169.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 188.30M | |||
| Accrued Expenses | 1.53M | 2.04M | 2.72M | 17.20M | 10.50M | |||
| Accounts Payable | 176.00K | 258.00K | 27.00K | 2.20M | 3.40M | |||
| Other Current Liabilities | 3.03M | 2.87M | 4.10M | 27.40M | 50.80M | |||
| Total Current Liabilities | 4.74M | 5.17M | 6.85M | 46.80M | 252.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 6.75M | 6.29M | 7.17M | 8.50M | 10.20M | |||
| Total Non-Current Liabilities | 6.75M | 6.29M | 7.17M | 8.50M | 10.20M | |||
| TOTAL LIABILITIES | 11.50M | 11.45M | 14.02M | 55.30M | 263.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -952.48M | -951.82M | -949.64M | -939.40M | -1.05B | |||
| Additional Paid In Capital | 979.20M | 979.18M | 978.92M | 974.50M | 957.70M | |||
| Common Shares | 11.00K | 11.00K | 11.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 11.57M | 11.53M | 11.53M | 9.50M | 8.60M | |||
| Tangible Book Value per Share | 1.95 | 2.00 | 2.01 | 2.97 | -11.71 | |||
| Total Shareholders' Equity | 26.74M | 27.37M | 29.29M | 35.10M | -93.60M | |||
| TOTAL LIABILITIES AND EQUITY | 38.24M | 38.82M | 43.31M | 90.50M | 169.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 2.64 | 2.37 | 1.72 | 1.18 | 0.47 | |||
| Return On Assets (ROA) | -5.49% | -5.62% | -23.73% | 123.76% | -101.72% | |||
| Return On Equity (ROE) | -7.85% | -7.97% | -35.09% | 319.09% | N/A | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 19.27% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 19.27% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | 22.88% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21